[47] And, leads to dampened systemic inflammation that may be relevant in autoimmune and chronic inflammatory diseases.[47][47][48][49] GLP-1 RA act as multi-faceted anti-inflammatory agents , suggesting they may delay or attenuate inflammation-driven tissue damage.[48][49] GLP-1 receptor agonists very often dampen immune responses
Although the precise mechanisms of action of Delta Sleep-Inducing Peptide (DSIP) are not fully understood, research suggests that DSIP peptide modulates multiple neurotransmitter systems, including glutamate, GABA, and serotonin
It is not approved by the FDA, EMA, or any regulatory authority for human therapeutic or diagnostic use
When you start taking GLP-1s, there are many new changes to navigate
The choice between B6 and B12 depends on your individual symptoms and goals, and your provider can help guide the best option based on your response to treatment
Buse et al., 2014)